Small-Molecule MDM2-p53 Inhibitors: Recent Advances
Year: 2015
Type: review
Abstract: Potent and selective small-molecule inhibitors of the p53-MDM2 interaction intended for the treatment of p53 wild-type tumors have been designed and optimized in a number of chemical series. This review details recent disclosures of compounds in advanced optimization and features key series that have given rise to clinical trial candidates. The structure-activity relationships for inhibitor classes are discussed with reference to x-ray structures, and common structural features are identified.
Source: Future Medicinal Chemistry
DOI: 10.4155/fmc.15.13
Institution: Newcastle University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: Cancer Research UK
OpenAlex ID: W2150518875
